Related references
Note: Only part of the references are listed.Long-term efficacy of interferon alpha therapy on hepatitis B viral replication in patients with chronic hepatitis B: A meta-analysis
Yong-Feng Yang et al.
ANTIVIRAL RESEARCH (2010)
Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B
Pisit Tangkijvanich et al.
HEPATOLOGY RESEARCH (2010)
Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment
Jin-Hai Chang et al.
LIVER INTERNATIONAL (2010)
Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2009)
Antiviral Effects of the Interferon-Induced Protein Guanylate Binding Protein 1 and Its Interaction with the Hepatitis C Virus NS5B Protein
Yasuhiro Itsui et al.
HEPATOLOGY (2009)
Mutations in the Interferon Sensitivity-Determining Region of Hepatitis C Virus Genotype 2a Correlate With Response to Pegylated-Interferon-Alpha 2a Monotherapy
Kazuhiko Hayashi et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection
Q. -M. Gong et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Cloning, eukaryotic expression of human ISG20 and preliminary study on the effect of its anti-HBV
Youltua Hao et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2008)
The Level of Hepatitis B Virus Replication Is Not Affected by Protein ISG15 Modification but Is Reduced by Inhibition of UBP43 (USP18) Expression
Jung-Hwan Kim et al.
JOURNAL OF IMMUNOLOGY (2008)
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C
T. Asselah et al.
GUT (2008)
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
Jordan J. Feld et al.
HEPATOLOGY (2007)
Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
F. Bonino et al.
GUT (2007)
Inhibition of alpha interferon signaling by hepatitis B virus
Verena Christen et al.
JOURNAL OF VIROLOGY (2007)
Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection
Glenn Randall et al.
GASTROENTEROLOGY (2006)
Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication
Y. Itsui et al.
JOURNAL OF VIRAL HEPATITIS (2006)
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Oxana A. Malakhova et al.
EMBO JOURNAL (2006)
Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling
KI Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Genetic structural differences between responders and non-responders to interferon therapy for chronic hepatitis-B patients
Pei-Jer Chen et al.
JOURNAL OF HUMAN GENETICS (2006)
Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice
KP Knobeloch et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients
Yong-Nian Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus
A Osiak et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
LM Chen et al.
GASTROENTEROLOGY (2005)
Genomic analysis of the host response to hepatitis B virus infection
S Wieland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regulation of hepatitis C virus replication by interferon regulatory factor 1
N Kanazawa et al.
JOURNAL OF VIROLOGY (2004)
A random variance model for detection of differential gene expression in small microarray experiments
GW Wright et al.
BIOINFORMATICS (2003)
ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses
L Espert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C
XH Ji et al.
HEPATOLOGY (2003)
Protein ISGylation modulates the JAK-STAT signaling pathway
OA Malakhova et al.
GENES & DEVELOPMENT (2003)
Antiviral activity of interferon-α against hepatitis B virus can be studied in non-hepatic cells and is independent of MxA
A Rang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice
LG Guidotti et al.
JOURNAL OF VIROLOGY (2002)
The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro
LH Nguyen et al.
BIOCHEMISTRY (2001)
Novel cell type-specific antiviral mechanism of interferon γ action in macrophages
RM Presti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
